sumatriptan has been researched along with Complications, Pregnancy in 12 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A systematic review of the medical literature was conducted to identify information regarding the safety of sumatriptan during pregnancy." | 8.82 | Safety of sumatriptan in pregnancy: a review of the data so far. ( Loder, E, 2003) |
| "To evaluate delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan." | 7.71 | Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan. ( Källén, B; Lygner, PE, 2001) |
| "5% of fertile Danish women use sumatriptan, and the drug is also taken during pregnancy." | 7.70 | Pregnancy outcome following prescription for sumatriptan. ( Nielsen, GL; Olesen, C; Olsen, J; Sorensen, HT; Steffensen, FH, 2000) |
| " A systematic review of the medical literature was conducted to identify information regarding the safety of sumatriptan during pregnancy." | 4.82 | Safety of sumatriptan in pregnancy: a review of the data so far. ( Loder, E, 2003) |
| "Using the Marketscan database, the risk of major birth defects was ascertained in live-born infants whose birth mothers were exposed to sumatriptan, naratriptan, or sumatriptan/naproxen during pregnancy." | 3.88 | Use of existing electronic health care databases to evaluate medication safety in pregnancy: Triptan exposure in pregnancy as a case study. ( Bollinger, L; Cangialose, C; Chia, V; Mikol, DD; Xue, F; Yusuf, A, 2018) |
| "Accumulated data suggest that exposure to sumatriptan during pregnancy does not increase the risk of birth defects above the baseline rate." | 3.76 | Safety of triptans for migraine headaches during pregnancy and breastfeeding. ( Bozzo, P; Duong, S; Einarson, A; Nordeng, H, 2010) |
| "To evaluate delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan." | 3.71 | Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan. ( Källén, B; Lygner, PE, 2001) |
| " The proportions of outcomes with birth defects are as follows: in the Acyclovir (antiviral medication) Pregnancy Registry (1984-1998) (19/581), 3." | 3.70 | Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment. ( Andrews, EB; Ephross, SA; Heffner, CR; Reiff-Eldridge, R; Tennis, PS; White, AD, 2000) |
| "5% of fertile Danish women use sumatriptan, and the drug is also taken during pregnancy." | 3.70 | Pregnancy outcome following prescription for sumatriptan. ( Nielsen, GL; Olesen, C; Olsen, J; Sorensen, HT; Steffensen, FH, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jarvis, S | 1 |
| Dassan, P | 1 |
| Piercy, CN | 1 |
| Yusuf, A | 1 |
| Chia, V | 1 |
| Xue, F | 1 |
| Mikol, DD | 1 |
| Bollinger, L | 1 |
| Cangialose, C | 1 |
| Hultzsch, S | 1 |
| Schaefer, C | 1 |
| Duong, S | 1 |
| Bozzo, P | 1 |
| Nordeng, H | 1 |
| Einarson, A | 1 |
| Williams, SH | 1 |
| Kehr, HA | 1 |
| Loder, E | 1 |
| Fox, AW | 1 |
| Reiff-Eldridge, R | 1 |
| Heffner, CR | 1 |
| Ephross, SA | 1 |
| Tennis, PS | 1 |
| White, AD | 1 |
| Andrews, EB | 1 |
| Olesen, C | 2 |
| Steffensen, FH | 1 |
| Sorensen, HT | 1 |
| Nielsen, GL | 1 |
| Olsen, J | 2 |
| Källén, B | 1 |
| Lygner, PE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Sumatriptan and Naratriptan Pregnancy Registry[NCT01059604] | 868 participants (Actual) | Observational [Patient Registry] | 2001-12-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for sumatriptan and Complications, Pregnancy
| Article | Year |
|---|---|
Migraine and pregnancy. Choice of treatment.
Topics: Abnormalities, Drug-Induced; Female; Fetus; Gestational Age; Humans; Migraine Disorders; Patient Sel | 2014 |
[Analgesic drugs during pregnancy].
Topics: Abnormalities, Drug-Induced; Acetaminophen; Acute Pain; Analgesics; Analgesics, Opioid; Anticonvulsa | 2016 |
An update in the treatment of neurologic disorders during pregnancy--focus on migraines and seizures.
Topics: Animals; Anticonvulsants; Female; Humans; Migraine Disorders; Nervous System Diseases; Pregnancy; Pr | 2012 |
Safety of sumatriptan in pregnancy: a review of the data so far.
Topics: Animals; Female; Humans; Migraine Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; | 2003 |
8 other studies available for sumatriptan and Complications, Pregnancy
| Article | Year |
|---|---|
Managing migraine in pregnancy.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Antiemetics; Female; Humans; Migraine with Aura; Pre | 2018 |
Use of existing electronic health care databases to evaluate medication safety in pregnancy: Triptan exposure in pregnancy as a case study.
Topics: Abnormalities, Drug-Induced; Administrative Claims, Healthcare; Adolescent; Adult; Databases, Factua | 2018 |
Safety of triptans for migraine headaches during pregnancy and breastfeeding.
Topics: Breast Feeding; Female; Humans; Migraine Disorders; Piperidines; Pregnancy; Pregnancy Complications; | 2010 |
Revised estimates for probability of successful outcome of pregnancy after sumatriptan exposure.
Topics: Abnormalities, Drug-Induced; Female; Humans; Infant, Newborn; Migraine Disorders; Pregnancy; Pregnan | 2004 |
Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment.
Topics: Abnormalities, Drug-Induced; Acyclovir; Anticonvulsants; Antiviral Agents; Drug Industry; Epilepsy; | 2000 |
Pregnancy outcome following prescription for sumatriptan.
Topics: Adult; Drug Prescriptions; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Maternal Expos | 2000 |
Sumatriptan: what do we know about fetal risks?
Topics: Denmark; Female; Humans; Infant, Newborn; Infant, Premature; Maternal Exposure; Migraine Disorders; | 2001 |
Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan.
Topics: Adult; Congenital Abnormalities; Delivery, Obstetric; Female; Humans; Infant, Newborn; Middle Aged; | 2001 |